Xenon Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.About XENE
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
CEOIan C. Mortimer
CEOIan C. Mortimer
Employees327
Employees327
HeadquartersBurnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded1996
Founded1996
Employees327
Employees327
XENE Key Statistics
Market cap2.41B
Market cap2.41B
Price-Earnings ratio-9.62
Price-Earnings ratio-9.62
Dividend yield—
Dividend yield—
Average volume1.72M
Average volume1.72M
High today$31.56
High today$31.56
Low today$30.72
Low today$30.72
Open price$30.86
Open price$30.86
Volume485.04K
Volume485.04K
52 Week high$46.00
52 Week high$46.00
52 Week low$26.74
52 Week low$26.74
XENE News
TipRanks 6d
Xenon Pharmaceuticals to Present at 2025 RBC Healthcare ConferenceConfident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive underval...
Analyst ratings
100%
of 19 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.